ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO141

Assessment of Renal Angina Index for the Prediction of Severe AKI in Critically Ill Adults

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • Neyra, Javier A., University of Kentucky Medical Center, Lexington, Kentucky, United States
  • Ortiz-Soriano, Victor M., University of Kentucky, Lexington, Kentucky, United States
  • Kabir, Shaowli, University of Kentucky, Lexington, Kentucky, United States
  • Claure-Del Granado, Rolando, Hospital Obrero #2 - C.N.S.; Universidad Mayor de San Simon, School of Medicine, Cochabamba, Cercado, Bolivia, Plurinational State of
  • Stromberg, Arnold James, University of Kentucky, Lexington, Kentucky, United States
  • Goldstein, Stuart, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Background

Risk-stratification tools of incident AKI in critically ill adults are needed. The renal angina index (RAI) was developed and validated in the pediatric population. We evaluated the performance of the RAI for the prediction of severe AKI in critically ill adults.

Methods

A cohort of 12,084 patients admitted to the ICU at the University of Kentucky (2009-2017) was utilized. Inclusion criteria consisted of age ≥18, ICU stay ≥3 days, at least 2 serum creatinine (SCr) measures in the first 2 days of ICU stay and one measure at 3-7 days of stay. Exclusion criteria consisted of ESKD, kidney transplant or baseline eGFR <15. A modified RAI (mRAI) included risk level criteria 1) mechanical ventilation or vasoactive drug support, 2) sepsis, and 3) diabetes and injury level criteria of 1) SCr increments (<25%, 25-49%, 50-99%, ≥100) and 2) fluid overload (FO%, <5%, 5-10%, 11-19%, ≥20%). Performance metrics were used for evaluation of components of the mRAI in reference to isolated changes in SCr.

Results

Mean (SD) age was 57.3 (16.5), 42% were women and 90% white. Mean (SD) SOFA score was 5.2 (3.0). The incidence of AKI (KDIGO-SCr) stage ≥2 at 3-7 days of ICU stay was 15.7%. Median [IQR] mRAI (determined in the first 2 days of ICU stay) was 24 [8-40] vs 10 [5-40], p<0.001 for those with vs without AKI stage ≥2 at 3-7 days. Performance metrics are reported in Table. Similar performance was observed when the cohort was restricted to patients without AKI or AKI stage ≤1 in the first 2 days of ICU stay.

Conclusion

When compared with examination of isolated changes in SCr, components of the mRAI exhibited better performance for the prediction of severe AKI in critically ill adults, particularly when measured baseline SCr was not available. The mRAI is a feasible risk-stratification tool that needs validation in the adult population.

Performance metrics (95%CI) of components of the mRAI for the prediction of AKI stage ≥2 in critically ill adults
 ΔSCr first 2 days of ICU staymRAI using ΔSCr first 2 days of ICU stayΔSCr first 2 days of ICU stay (ref: measured baseline)mRAI using ΔSCr first 2 days of ICU stay (ref: measured baseline)
AUC0.59 (0.58, 0.60)0.70 (0.69, 0.72)*0.85 (0.84, 0.87)0.87 (0.85, 0.88)*
Absolute IDIref0.05 (0.04, 0.05)*ref0.01 (0.002, 0.01)*

*p<0.001 for performance comparison to corresponding reference; AUC = area under the receiving operating characteristic curve; IDI = integrated discrimination index; SCr = serum creatinine